Skip to main content

Investigation of the FZD8-Fc Wnt Ligand Antagonist and the Fzd Receptor Monoclonal Antibody in Combination with Immune Checkpoint Blockade in Pre-Clinical Melanoma, Non-Small Cell Lung Cancer, and Col

Research Grant
Duke Scholars

Administered By

Medicine, Medical Oncology

Awarded By

OncoMed Pharmaceuticals

Start Date

October 16, 2015

End Date

October 16, 2018
 

Administered By

Medicine, Medical Oncology

Awarded By

OncoMed Pharmaceuticals

Start Date

October 16, 2015

End Date

October 16, 2018